DexCom Net Working Capital vs Short Term Debt Analysis

DXCM Stock  USD 74.46  0.78  1.04%   
DexCom financial indicator trend analysis is much more than just examining DexCom Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DexCom Inc is a good investment. Please check the relationship between DexCom Net Working Capital and its Short Term Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Net Working Capital vs Short Term Debt

Net Working Capital vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DexCom Inc Net Working Capital account and Short Term Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between DexCom's Net Working Capital and Short Term Debt is 0.17. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of DexCom Inc, assuming nothing else is changed. The correlation between historical values of DexCom's Net Working Capital and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of DexCom Inc are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Net Working Capital i.e., DexCom's Net Working Capital and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.17
Relationship DirectionPositive 
Relationship StrengthInsignificant

Net Working Capital

Short Term Debt

Most indicators from DexCom's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
At this time, DexCom's Selling General Administrative is very stable compared to the past year. As of the 22nd of November 2024, Tax Provision is likely to grow to about 177.3 M, while Issuance Of Capital Stock is likely to drop about 19.7 M.

DexCom fundamental ratios Correlations

0.980.950.70.970.51.00.930.940.990.810.920.980.820.960.810.970.970.680.990.960.810.980.940.980.99
0.980.890.750.980.560.980.860.890.970.730.880.950.720.920.720.940.940.760.960.90.720.940.970.970.97
0.950.890.460.880.350.930.970.940.960.90.870.970.890.970.890.920.970.470.970.980.890.960.860.960.94
0.70.750.460.810.580.750.450.510.620.240.710.570.440.520.310.730.560.860.670.520.310.580.690.640.73
0.970.980.880.810.550.990.830.850.930.680.910.910.750.880.680.970.910.80.960.870.680.90.940.970.98
0.50.560.350.580.550.520.330.420.480.060.550.440.310.380.340.450.440.790.450.380.340.440.490.480.49
1.00.980.930.750.990.520.90.910.970.760.930.960.810.940.770.980.950.720.990.940.770.950.940.981.0
0.930.860.970.450.830.330.90.950.950.940.810.970.870.980.940.90.960.380.950.990.940.970.850.890.91
0.940.890.940.510.850.420.910.950.970.880.850.980.860.970.930.850.970.50.940.950.930.970.840.90.92
0.990.970.960.620.930.480.970.950.970.850.91.00.810.970.860.930.980.60.980.970.861.00.920.960.97
0.810.730.90.240.680.060.760.940.880.850.620.890.770.920.880.760.870.120.840.910.880.880.760.790.78
0.920.880.870.710.910.550.930.810.850.90.620.870.810.810.740.920.850.730.920.870.740.880.770.90.94
0.980.950.970.570.910.440.960.970.981.00.890.870.830.990.90.920.980.550.980.980.91.00.910.950.96
0.820.720.890.440.750.310.810.870.860.810.770.810.830.850.880.820.870.410.870.870.880.810.660.80.85
0.960.920.970.520.880.380.940.980.970.970.920.810.990.850.890.910.990.490.960.970.890.980.920.940.94
0.810.720.890.310.680.340.770.940.930.860.880.740.90.880.890.750.880.270.850.921.00.890.680.760.8
0.970.940.920.730.970.450.980.90.850.930.760.920.920.820.910.750.910.660.980.930.750.930.910.960.99
0.970.940.970.560.910.440.950.960.970.980.870.850.980.870.990.880.910.570.970.960.880.970.920.960.95
0.680.760.470.860.80.790.720.380.50.60.120.730.550.410.490.270.660.570.620.460.270.540.680.680.69
0.990.960.970.670.960.450.990.950.940.980.840.920.980.870.960.850.980.970.620.980.850.980.910.970.99
0.960.90.980.520.870.380.940.990.950.970.910.870.980.870.970.920.930.960.460.980.920.990.870.930.95
0.810.720.890.310.680.340.770.940.930.860.880.740.90.880.891.00.750.880.270.850.920.890.680.760.8
0.980.940.960.580.90.440.950.970.971.00.880.881.00.810.980.890.930.970.540.980.990.890.910.940.96
0.940.970.860.690.940.490.940.850.840.920.760.770.910.660.920.680.910.920.680.910.870.680.910.940.92
0.980.970.960.640.970.480.980.890.90.960.790.90.950.80.940.760.960.960.680.970.930.760.940.940.98
0.990.970.940.730.980.491.00.910.920.970.780.940.960.850.940.80.990.950.690.990.950.80.960.920.98
Click cells to compare fundamentals

DexCom Account Relationship Matchups

DexCom fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.4B4.3B4.9B5.4B6.3B6.6B
Total Stockholder Equity882.6M1.8B2.3B2.1B2.1B2.2B
Net Debt699.5M1.0B769.2M1.4B2.0B2.1B
Cash446.2M817.6M1.1B642.3M566.3M594.6M
Cash And Short Term Investments1.5B2.7B2.7B2.5B2.7B2.9B
Common Stock Shares Outstanding369.2M390M428.8M427.5M425.5M246.4M
Liabilities And Stockholders Equity2.4B4.3B4.9B5.4B6.3B6.6B
Total Current Assets2.0B3.4B3.7B3.7B4.4B4.6B
Other Current Liab88.5M400.3M447.6M753.4M1.2B1.2B
Total Current Liabilities360.2M614.1M720.8M1.8B1.6B1.6B
Property Plant And Equipment Net392.8M608.6M889.9M1.1B1.2B1.2B
Retained Earnings(695.7M)(202.1M)(47.4M)479.9M1.0B1.1B
Accounts Payable256.4M163.3M189.4M237.9M276.4M290.2M
Non Current Assets Total425.6M865.7M1.2B1.7B1.8B1.9B
Non Currrent Assets Other14.2M21.4M(4.5M)28.1M36.5M38.3M
Other Assets14.2M237.8M220.8M369.3M424.7M445.9M
Non Current Liabilities Total1.2B1.8B1.9B1.4B2.6B2.8B
Other Current Assets30M107.8M79.3M153.7M154.7M162.4M
Other Stockholder Equity1.6B2.0B1.9B1.7B1.1B1.1B
Total Liab1.5B2.5B2.6B3.3B4.2B4.4B
Property Plant And Equipment Gross392.8M608.6M801.8M1.1B1.7B1.8B
Accumulated Other Comprehensive Income2.3M3.2M500K(11.6M)(16.7M)(15.9M)
Property Plant Equipment321.3M515.3M889.9M1.1B1.3B1.4B
Other Liab5.7M80.9M90M68.7M79.0M83.0M
Short Term Investments1.1B1.9B1.7B1.8B2.2B2.3B
Short Long Term Debt Total1.1B1.8B1.8B2.1B2.6B2.7B
Long Term Debt1.1B1.7B1.7B1.2B2.4B2.6B
Net Receivables286.3M428.5M516.6M752.2M987.5M1.0B
Inventory119.8M234.7M357.3M306.7M559.6M587.6M
Short Term Debt13.6M33M41M793.1M21.1M20.0M
Current Deferred Revenue1.7M2.2M2.1M10.1M18.4M19.3M
Net Tangible Assets864M1.8B2.2B2.1B2.5B2.6B
Good Will18.6M19.3M26.5M25.7M25.2M14.4M
Retained Earnings Total Equity(695.7M)(202.1M)(47.4M)479.9M551.9M579.5M
Capital Surpluse1.7B2.1B2.5B2.3B2.6B1.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.157
Earnings Share
1.65
Revenue Per Share
10.089
Quarterly Revenue Growth
0.02
Return On Assets
0.0606
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.